IP Verse

Crispr-Based Genome Modification And Regulation

Patent No. EP3138910 (titled "Crispr-Based Genome Modification And Regulation") was filed by Sigma Aldrich on Dec 5, 2013. The application was issued on Sep 20, 2017.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (10)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MATHYS & SQUIREJun 20, 2018WILDING
POHLMANJun 20, 2018POHLMAN
RAHMSTORFJun 20, 2018GRUND
SCHLICHJun 20, 2018SCHLICH
MURPHYJun 20, 2018COOLEY UK
BASFJun 19, 2018EISENFUHR SPEISER
HGFJun 13, 2018HGF
CARIBOU BIOSCIENCESApr 12, 2018GRUND
COHAUSZ & FLORACK PATENT UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBMar 29, 2018COHAUSZ & FLORACK
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBDec 22, 2017VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3138910

SIGMA ALDRICH
Application Number
EP16183723A
Filing Date
Dec 5, 2013
Status
Revoked
Jul 8, 2022
Publication Date
Sep 20, 2017
External Links
Slate, Register , Google Patents